By the Chinese society of biomedical engineering of tumor molecular target to treatment professional committee and Nanjing University School of Medicine Affiliated Drum Tower Hospital host, Drum Tower Hospital hosted the "Fourth China tumor molecular target to the treatment of the General Assembly" on April 20 to April 22 in Nanjing held. The opening ceremony of the general assembly by the Drum Tower Hospital oncology director Professor Liu Baorui, President Ding Yitao attended and enthusiastic speech. The conference attracted a total of more than 300 people from domestic and foreign tumor molecular targeted therapy in the field of well-known experts and scholars. Ding, academician of Chinese Academy of engineering, academician Yu Jin Ming, European Association for the tumor of chest tumor group chairman Rafael Rosell Professor, University of Chicago in the United States mark Farrel Kozloff professor and South Korea Seoul University Yung Jue Bang Professor dozens of domestic and foreign experts has made a high level of academic report report.

During the conference, one hundred Tai Biological Pharmaceutical Co., Ltd. held a satellite. The satellite will be presided over by the director of the Department of tumor; Nanjing Gulou Hospital Professor Liu Baorui, Professor Chen, director of Professor Tao min, director of the Department of Oncology; the First Affiliated Hospital of Suzhou, and General Hospital of Nanjing Military Area Command of oncology, CO chaired the expert evaluation. Satellite, Suzhou University; Changzhou Tumor Hospital; - Yang Quan Liang director, Jiangsu Province Tumor Hospital radiotherapy department - Zhu Xiangzhi director, Jiangsu Provincial People's Hospital - Wang Jian, director of the, and everybody shared use Xintai classical cases. The number of satellites in the satellite will be over a hundred, far beyond the expected number.